<strong>How is Retatrutide administered?</strong>

Like other GLP-1 medications, it is a <strong>once-weekly subcutaneous injection</strong> that patients can safely perform at home.

Home Weight Loss Tips & Guides

9Jan

How Does Retatrutide Make You Lose Weight? The Science of the “Triple G” Agonist

Author: Dr. Aleksandr Shapsis, MD

Key Takeaways:

As the Tristate leader in non-surgical weight loss, EndoSlim Clinic NY is at the forefront of metabolic medicine. Retatrutide is a groundbreaking “triple agonist” currently in Phase 3 trials that is redefining what is possible without surgery:

✨ Triple-Action Mechanism: Unlike Wegovy® (1 receptor) or Zepbound™ (2 receptors), Retatrutide targets three hormones: GLP-1, GIP, and Glucagon.
✨ Surgical-Level Results: Latest 2026 data shows an average weight loss of 28.7% to 30% over 68 weeks—matching the efficacy of some bariatric surgeries.
✨ Metabolic Boost: By activating the glucagon receptor, it increases resting energy expenditure, helping you burn more fat even while at rest.
✨ Beyond the Scale: Clinical trials show an 80% reduction in liver fat and significant relief from chronic knee pain and sleep apnea.
✨ Future Availability: While currently investigational, it is expected to seek FDA approval in late 2026 or early 2027.

✨Retatrutide is an investigational medication not approved by the FDA for routine clinical use. Information provided by EndoSlim Clinic NY is for educational purposes only and does not constitute medical advice, diagnosis, or treatment.

Contents show

The “Triple-G” Breakthrough: How Retatrutide Targets Three Metabolic Pathways

The weight-loss landscape has evolved rapidly from single-hormone injections to the “triple-action” power of Retatrutide. At EndoSlim Clinic NY, Dr. Alexander Shapsis describes this medication as a metabolic “multi-tool.” While existing drugs primarily focus on appetite, Retatrutide adds a direct fat-burning component.

1. GLP-1 (Appetite Suppression)

Retatrutide mimics the Glucagon-Like Peptide-1 (GLP-1) hormone. This is the foundation of modern weight-loss drugs. It slows down gastric emptying—keeping food in your stomach longer—and signals the “satiety” centers of the brain to stop cravings and intrusive thoughts about food.

2. GIP (Metabolic Efficiency)

Like Zepbound™, Retatrutide activates the Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor. GIP helps regulate insulin levels and improves the way your body processes fat. It also plays a crucial role in reducing the nausea and gastrointestinal discomfort often associated with high-dose GLP-1 therapy.

3. Glucagon (The Energy Burner)

This is the “Third G” that makes Retatrutide unique. In previous generations of drugs, glucagon was suppressed. Retatrutide activates it to:

Increase Thermogenesis: It raises your resting metabolic rate, meaning your body burns more calories throughout the day.
Promote Lipolysis: It triggers the liver and fatty tissues to break down stored fat more aggressively for use as energy.

New York’s Leading Non-Surgical Bariatric & Endoscopic Weight-Loss Doctor

Comparing the Giants: Retatrutide vs. Wegovy® vs. Zepbound™

Feature	Semaglutide (Wegovy®)	Tirzepatide (Zepbound™)	Retatrutide (Triple G)
Receptors Targeted	1 (GLP-1)	2 (GLP-1 + GIP)	3 (GLP-1 + GIP + Glucagon)
Avg. Weight Loss	~15%	~22.5%	Up to 30%
Fat Burning	Indirect	High	Highest (Direct Activation)
Liver Fat Reduction	Moderate	Significant	Near-Total Clearance (80%+)

Clinical Benefits Beyond Weight Loss: Liver and Joint Health

In the most recent TRIUMPH-4 Phase 3 results (December 2025), Retatrutide demonstrated that its impact extends far beyond the number on the scale. For patients in the Tri-State area with complex health profiles, these benefits are life-changing:

Reversing Fatty Liver: Retatrutide cleared liver fat so effectively that 89% to 93% of participants reached healthy liver fat levels (below 5%) during trials.
Osteoarthritis Relief: Patients reported an average 75.8% reduction in knee pain, with many becoming entirely pain-free due to the combination of rapid weight loss and reduced inflammation.
Cardiovascular Protection: The drug significantly lowered blood pressure and improved cholesterol, even in patients who were previously resistant to standard treatments.

Frequently Asked Questions (FAQs)

Is Retatrutide available for purchase in Brooklyn yet?

No. As of early 2026, Retatrutide is still in Phase 3 clinical trials. It is not yet FDA-approved or commercially available. We expect potential approval in late 2026 or 2027.

How is Retatrutide administered?

Like other GLP-1 medications, it is a once-weekly subcutaneous injection that patients can safely perform at home.

What are the side effects of a triple-agonist?

The most common side effects are gastrointestinal, such as nausea, diarrhea, and constipation. Because it acts on the glucagon receptor, some patients in trials also experienced a temporary increase in resting heart rate.

Can I switch to Retatrutide if I plateaued on Zepbound™?

While formal protocols will follow FDA approval, medical experts believe Retatrutide will be the next step for “non-responders” who need the extra metabolic boost of glucagon activation.

Does Retatrutide cause more muscle loss than other drugs?

Early data indicates that the ratio of fat-to-muscle loss is similar to other bariatric procedures. Dr. Shapsis emphasizes a protein-first diet and resistance training to preserve lean mass during rapid weight loss.

Is Retatrutide a “miracle” drug for fatty liver?

It is one of the most promising treatments ever studied for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), showing a near-complete clearance of liver fat in high-dose trial participants.

Will EndoSlim Clinic NY offer Retatrutide?

Yes. As leaders in advanced endoscopic and medical bariatrics, we will offer Retatrutide as soon as it receives FDA approval and is available for prescription.

Take the Next Step Toward Your Health Goals

While we await the final approval of Retatrutide, you don’t have to wait to start your transformation. EndoSlim Clinic NY offers the most advanced non-surgical tools currently available, from ESG (Endoscopic Sleeve Gastroplasty) to the latest therapeutic doses of Zepbound™ and Wegovy®

Contact us today to schedule your metabolic evaluation with Dr. Alexander Shapsis.

📍 Location: 2797 Ocean Pkwy Suite 1, Brooklyn, NY 11235 📞 Call: 877-749-3633

Useful Links:

Medical Disclaimer: The content on this blog is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Retatrutide is currently an investigational drug and is not FDA-approved. Always seek the advice of a qualified healthcare provider, such as Dr. Alexander Shapsis, regarding your health. In case of a medical emergency, call 911 immediately.

Get Started

Book an appointment and take the first step in your weight loss journey.

Book Now

Our Services